Frequently Asked Questions (FAQs)

The FAQs are designed to address questions from prospective applicant institutions. The FAQs do not address potential questions from individuals who hope to ultimately be hired as part of a cohort at a future FIRST Cohort awardee institution. 

Click on the drop down arrow to learn more about each new RFA. Please check back as this page is updated with new information often.



Why is this FIRST program being funded through the NIH Common Fund?

  • The Common Fund supports programs that are intended to have a transformative impact on biomedical research conducted across all NIH Institutes and Centers. Common Fund programs encourage highly innovative approaches to broadly relevant challenges, coordination among awardees, and rapid dissemination of results and lessons learned. These programs represent NIH-wide priorities, and program areas are selected with input from all Institute and Center Directors and from extramural scientists. Common Fund support of the FIRST program is indicative of the recognition by NIH Leadership that talent from all sectors of the population is necessary to accomplish the NIH mission.
  • This program is a high priority for NIH as a whole.

Where does funding for this FIRST program come from?

  • Funding for FIRST comes from the NIH Common Fund. The FOAs will be administered by a trans-NIH team, led by the National Cancer Institute (NCI) and National Institute on Minority Health Disparities (NIMHD) together with a group of NIH staff from multiple institutes, centers, and offices across the NIH.



This page last reviewed on January 22, 2021